JAMDA
Volume 10, Issue 1 , Pages 28-35 , January 2009

Assessing the Quality of Evidence From Randomized, Controlled Drug and Nutritional Supplement Trials Conducted Among Nursing Home Residents Between 1968 and 2004: What Can We Learn?

  • Huai Yong Cheng, MPH, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Huai Yong Cheng, MPH, MD, Division of Geriatric Medicine and Geriatrics, Columbia University, 5141 Broadway, New York, NY 10034

References 

  1. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: What it is and what it isn't. BMJ. 1996;312:71–72
  2. Guyatt GH, Haynes B, Jaeschke RZ, et al. Users' guides to the medical literature: XXV (Evidence-based medicine: Principles for applying the users' guides to patient care). JAMA. 2000;284:1290–1296
  3. Mitka M. Too few older patients in cancer trials. JAMA. 2003;290:27–28
  4. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708–713
  5. Schmucker DL, Vesell ES. Are the elderly underrepresented in clinical drug trials?. J Clin Pharmacol. 1999;39:1103–1108
  6. Cameron HJ, Williams BO. Clinical trials in the elderly (Should we do more?). Drugs Aging. 1996;9:307–310
  7. Gabrel CS. Characteristics of elderly nursing home current residents and discharges: Data from the 1997 National Nursing homes Survey. Advance Data from vital and health statistics; no. 312. Hyattsville, MD: National Center for Health Statistics; 2000;
  8. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc. 2005;53:438–443
  9. Messinger-Rapport BJ. Evidence-based medicine: is it relevant to long-term care?. J Am Med Dir Assoc. 2004;5:328–332
  10. Cheng HY. Evidence-based medicine in long-term care. J Am Med Dir Assoc. 2005;6:168–169
  11. Le Quintrec JL, Bussy C, Golmard JL, et al. Randomized controlled drug trials on very elderly subjects: Descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults. J Gerontol A Biol Sci Med Sci. 2005;60A:340–344
  12. Epstein AM. Paying for performance in the United States and abroad. N Eng J Med. 2006;355:406–408
  13. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol. 2002;31:150–153
  14. Meinert CL, Tonascia S, Higgins K. Content of reports on clinical trials: A critical review. Control Clin Trials. 1984;5:328–347
  15. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125–128
  16. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials—The CONSORT statement. JAMA. 1996;276:637–639
  17. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001;134:663–694
  18. Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ. 2001;323:42–46
  19. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there?. Ann Intern Med. 2002;137:10–16
  20. Sánchez-Thorin JC, Cortés , Montenefro M, Villate N. The quality of reporting of randomized clinical trials published in Ophthalmology. Ophthalmology. 2001;108:410–415
  21. Latronico N, Botteri M, Minelli C, et al. Quality of reporting of randomized controlled trials in the intensive care literature—a systemic analysis of papers published in Intensive Care Medicine. Intensive Care Med. 2002;28:1316–1323
  22. Moher D, Jadad AR, Michol G, et al. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Controlled Clin Trials. 1995;16:62–73
  23. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282:1054–1060
  24. Guyatt GH, Sackett DL, Cook DJ Evidence-Based Medicine Working Group. User' guides to the medical literature, II (How to use an article about therapy or prevention. A. Are the results of the study valid?). JAMA. 1993;270:2598–2601
  25. Guyatt GH, Sackett DL, Cook DJ Evidence-Based Medicine Working Group. User' guides to the medical literature, II (How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients?). JAMA. 1994;271:59–63
  26. Dans AL, Dans LF, Guyatt GH, Richardson S Evidence-Based Medicine Working Group. User' guides to the medical literature, XIV (How to decide on the applicability of clinical trial results to your patient). JAMA. 1998;279:545–549
  27. Britton A, McKee M, Black N, et al. Threats to applicability of randomized trials: Exclusions and selective participation. J Health Serv Res Policy. 1999;4:112–121
  28. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet. 2002;360:1623–1630
  29. Chan AW, Altman DG. Epidemiology and reporting of randomized trials published in PubMed journals. Lancet. 2005;365:1159–1162
  30. Stephan F, Gøtzsche M, Gøtzsche PC. Sample size of randomized double-blind trials 1976–1991. Dan Med Bull. 1996;43:96–98
  31. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272:122–124
  32. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ. 1948;2:769–782
  33. Bravo D, Dubois MF, Hébert R, et al. A prospective evaluation of the Charlson Comorbidity Index for use in long-term care patients. J Am Geriatr Soc. 2002;50:740–745
  34. Altman DG. Poor-quality medical research—What can journals do?. JAMA. 2002;287:2765–2767
  35. Altman DG. The scandal of poor medical research. BMJ. 1994;308:283–284
  36. Moher D, Jones A, Lepage L CONSORT group. Use of the CONSORT statement and quality of reports randomized trials—A comparative before-and-after evaluation. JAMA. 2001;285:1992–1995
  37. Dolinar RO, Leininger SL. Pay for performance means compliance-based care. J Am Med Dir Assoc. 2006;7:328–333
  38. Boyd CM, Darer J, Bout C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases—Implications for Pay for Performance. JAMA. 2005;294:716–724
  39. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004;170:477–480
  40. Kennedy D. The old file-drawer problem. Science. 2004;305:451
  41. Meydani SN, Leka LS, Fine BS, et al. Vitamin E and respiratory tract infections in elderly nursing home residents- a randomized controlled trial. JAMA. 2004;292:828–836
  42. Meguro K, Meguro M, Tanaka Y, et al. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. J Geriatr Psychiatry Neurol. 2004;17:61–67
  43. McElbaney JE, Granvenstein S, Cole SK, et al. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc. 2004;52:13–19
  44. Landi F, Aloe L, Russo A, et al. Topical treatment of pressure ulcers with nerve growth factor-a randomized clinical trial. Ann Intern Med. 2003;139:635–641
  45. Brodaty H, Ames D, Snowdon J, et al. A randomized placebo-controlled trial of resperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry. 2003;64:134–143
  46. Oslin DW, Ten Have TR, Streim JE, et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry. 2003;64:875–882
  47. Fontanine CS, Hynan LS, Koch K, et al. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry. 2003;64:726–730
  48. Burrows AB, Salzman C, Satlin A, et al. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depression and Anxiety. 2002;15:102–110
  49. Meyer HE, Smedshaug GB, Kvaavik E, et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? (A randomized controlled trial). JBMR. 2002;17:709–715
  50. Wouters-Wesseling W, Wouters AEJ, Kleijer CN, et al. Study of the effect of a liquid nutrition supplement on the nutritional status of psycho-geriatric nursing home patients. European J Clin Nutrition. 2002;56:245–251
  51. Tariot PN, Cummings JL, Katz IR, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc. 2001;49:1590–1599
  52. Ouslander JG, Greendale GA, Uman G, et al. Effect of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc. 2001;49:803–807
  53. Rhodes RS, Heyneman CA, Culbertson VL, et al. Topical phenytoin treatment of satge II decubitus ulcers in the elderly. Ann Pharmacther. 2001;35:675–681
  54. Porsteinsson AP, Tariot PN, Erb R, et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry. 2001;9:58–66
  55. Tariot PN, Schneider LS, Mintzer JE, et al. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Current Therapeutic Research. 2001;62:51–67
  56. Kwok T, Woo J, Kwan M. Does low lactose mild power improve the nutritional intake and nutritional status of frail older Chinese people living in nursing homes?. J Nutrition, Health & Aging. 2001;5:17–21
  57. Yeh SS, Wu SY, Lee TP, et al. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study. J Am Geriatr Soc. 2000;48:485–492
  58. Oslin DW, Streim JE, Katz IR, et al. Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients. Am J Geriatr Psychiatry. 2000;8:141–149
  59. Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J Geriatr Psychiatry. 2000;8:66–74
  60. Lauque S, Arnaud-Battandier F, Mansourian R, et al. Protein-energy oral supplementation in malnourished nursing-home residents (A controlled trial). Age and Ageing. 2000;29:51–56
  61. Street JS, Clark W, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities. Arch Gen Psychiatry. 2000;57:968–976
  62. Singh MAF, Bernstein MA, Ryan ND, et al. The effect of oral nutritional supplements on habitual dietary quality and quantity in frail elders. Journ of Nutr Health & Aging. 2000;1:5–12
  63. Chassagne P, Jego A, Gloc P, et al. Does treatment of constipation improve faecal incontinence in institutionalized elderly patients?. Age and Ageing. 2000;29:159–164
  64. Filip V, Kolibás E. Selgiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. J Psychiatry Neurosci. 1999;24:234–243
  65. Schilling M, Povine L, Krause P, et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine. 1998;16:1771–1774
  66. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155:54–61
  67. Galan P, Preziosi P, Monget AL, et al. Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metobolism and immunological markers in elderly long term-hospitalized subjects. Internat J Vit Nutr Res. 1997;67:450–460
  68. Monget AL, Richard MJ, Cournot MP, et al. Effect of 6 month supplementation with different combinations of an association of antitoxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. European J Clin Nutrition. 1996;443–449
  69. Nicolle LE, Kirshen A, Boustcha E, Montgomery P. Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents. Infectious Diseases in Clinical Practice. 1996;5:130–137
  70. Monto AS, Ohmit SE, Hornbuckle K, et al. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes. Antimicrob Agents Chemother. 1995;39:2224–2228
  71. van der Wielen RPJ, van Heereveld HAEM, de Groot CPGM, van Staveren WA. Nutritional status of elderly female nursing home residents; the effect of supplementation with a physiological dose of water-soluble vitamins. European J Clin Nutrition. 1995;49:665–674
  72. McCue JD, Gaziano P, Orders D. A randomized controlled trial of ofloxacin 200mg 4 times daily or twice daily vs ciprofloxacin 500mg twice daily in elderly nursing home patients with complicated UTI. Drugs. 1995;49(Suppl. 2):368–373
  73. Banting DW, Greeenorn PA, McMinn JG. Effectiveness of a topical antifungal regimen for the treatment of oral candiaiasis in older, chronically ill, institutionalized, adults. J Can Dent Assoc. 1995;61:199–200203-2-5
  74. Ouslander JG, Shapira M, Schnelle JF, et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?. Ann Intern Med. 1995;122:749–754
  75. Clark DC, Guest JL. The effectiveness of three different strengths of chlorhexidine mouthrinse. Journal-Canadian Dental Association. 1994;60:711–714
  76. Phillips SL, Branaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftraxone in patients with nursing home-acquired pneumonia. J Am Geriatr Soc. 1993;41:1071–1074
  77. Murphy S, West KP, Greenough WB, et al. Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age and Ageing. 1992;21:435–439
  78. Gerding GA, Browning JS. Oxyquinoline-contaning ointment vs. standard therapy for stage I and stage II skin lesions. Dermatology Nursing. 1992;4:389–398
  79. Hirata-Dulas CA, Stein DJ, Guay DRP, et al. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc. 1991;39:979–985
  80. Himmelstein S, Clemens TL, Rubin A, Lindsay R. Vitamin D supplementation in elderly nursing home residents increase 25(OH) D but not 1,25 (OH)2 D. Am J Clin Nutr. 1990;52:701–706
  81. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for aymptomatic bacteria in institutionalized elderly women. Am J Med. 1987;83:27–33
  82. Gaitz CM, Varner RV, Overall JE. Pharmacothrapy for organic brain syndrome in late life. Arch Gen Psychiatry. 1977;34:839–845

 The author is the recipient of a Geriatric Academic Career Award (GACA). This project is partially supported by funds from the Bureau of Health Professions (BHPr), Health Resources and Service Administration (HRSA), Department of Health and Human Services (DHHS), under the grant of GACA. The information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by the BHPR, HRSA, DHHS, or the US government.

PII: S1525-8610(08)00252-1

doi: 10.1016/j.jamda.2008.06.005

JAMDA
Volume 10, Issue 1 , Pages 28-35 , January 2009

Article Tools

* Image Usage & Resolution